NR3C2 and obstructive sleep apnea syndrome: In the whole cohort, obstructive sleep apnea, treatment by aldosterone receptor antagonist, PWD, EAT LA-esophagus and EAT LA-mitral isthmus were selected as variables (p < 0.10) for a multivariate analysis.